ChromaDex's Yasmeen Nkrumah-Elie Wins Trailblazing Woman Award
Yasmeen Nkrumah-Elie Recognized for Her Impact in Nutrition
ChromaDex Corp. (NASDAQ:CDXC), a leader in nicotinamide adenine dinucleotide (NAD+) research, has announced a significant achievement recognized by industry peers. Yasmeen Nkrumah-Elie, Ph.D., serves as the company’s Global Director of External Research and has recently received the prestigious Trailblazing Woman Award from Radicle Science and the Council for Responsible Nutrition.
The Importance of the Trailblazing Woman Award
The Trailblazing Woman Award celebrates exceptional women who have made profound contributions to the dietary supplement and functional food industries. Dr. Nkrumah-Elie's distinguished career has been marked by her unwavering commitment to scientific advancement, her advocacy for diversity, and her mentorship of aspiring female leaders in the field.
A Message from Dr. Nkrumah-Elie
Upon receiving this honor, Dr. Nkrumah-Elie expressed her heartfelt gratitude, stating, "I am deeply honored to receive the Trailblazing Woman Award. The inspiring women in our industry demonstrate how we can push boundaries together. I am proud to play a role in a sector dedicated to enhancing wellness and global health." Her words reflect the collaborative spirit that drives progress in nutrition science.
Commitment to Advancing Science
In her pivotal role at ChromaDex, Dr. Nkrumah-Elie engages deeply with various scientific and regulatory bodies. She is an active member of the Senior Scientific Advisory Council of CRN and works tirelessly with organizations like Women In Nutraceuticals (WIN) and the American Society for Nutrition. Through speaking engagements and collaborations, she bridges scientific knowledge with public understanding, enhancing nutritional literacy.
Achievements of ChromaDex's External Research Program
Dr. Nkrumah-Elie has adeptly led the ChromaDex External Research Program (CERP), transforming it into an acclaimed initiative that engages in nearly 300 research collaborations globally. Under her direction, CERP has cultivated over 30 published clinical trials and identified numerous intellectual property opportunities, reinforcing its position as a benchmark for industry-academia collaboration.
Industry Recognition
Industry leaders have commended Dr. Nkrumah-Elie's contributions. Andrew Shao, Ph.D., Senior Vice President at ChromaDex, noted the evolution of CERP under her guidance, emphasizing how her leadership has set new standards for research quality and partnerships. Pelin Thorogood, Co-Founder of Radicle Science, highlighted her multifaceted impact beyond mere research, alluding to her role as a mentor and advocate for women in science.
About ChromaDex and Its Mission
ChromaDex Corp. stands as a pillar in advancing the science of healthy aging through NAD+ research. Their dedication is evident in their flagship product, Niagen, a patented nicotinamide riboside. Niagen's efficiency as a NAD+ booster has made it the top choice in the healthy aging supplement market. As people age, maintaining adequate NAD+ levels is crucial for preserving health and vitality.
By adhering to rigorous scientific and safety standards, ChromaDex demonstrates its commitment to transparency and quality in the development of nutritional supplements. They work alongside esteemed research institutions to maximize the benefits of NAD+ for consumers.
Consumer Reach and Future Innovations
Tru Niagen, the consumer-facing brand of Niagen, has become a leading choice in the United States for individuals seeking to improve their health as they age. As a testament to its effectiveness, the product is backed by clinical studies that substantiate its ability to enhance NAD+ levels.
Frequently Asked Questions
Who is Yasmeen Nkrumah-Elie?
Yasmeen Nkrumah-Elie, Ph.D., is the Global Director of External Research at ChromaDex and has been recognized for her contributions to the dietary supplement industry.
What is the Trailblazing Woman Award?
This award honors women who have made exceptional impacts in the dietary supplement and functional food industries, highlighting their leadership and innovation.
What is ChromaDex known for?
ChromaDex is known for its research on nicotinamide adenine dinucleotide (NAD+) and its clinically proven ingredient, Niagen.
What role does Dr. Nkrumah-Elie play at ChromaDex?
She leads the External Research Program and fosters collaborations with various scientific organizations to advance research in nutrition.
Why is NAD+ important for health?
NAD+ is a vital coenzyme found in all human cells. Its levels decline with age, and maintaining adequate NAD+ is essential for supporting overall health and vitality.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- Albuquerque Economic Alliance Achieves Prestigious Awards
- Teamsters Achieve Major Wins with Sysco Contract Renewal
- Spotlight on the 2024 Rawlings Gold Glove Award Finalists
- Health Benefit Alliance Earns 2024 Luminaries Award for Access
- Lee Howard Receives Prestigious Gold Globee Award for Leadership
- Cardiex Triumphs in NIH Challenge, Securing $525,000 Award
- Alan Vinegrad Awarded for Excellence in Legal Professionalism
- Stride Inc. Excels as Finalist in Multiple Tech Education Awards
- KWIKOM Communications Earns Prestigious Kansas Business Award
- CSG Forte Engage Garners Prestigious Awards for Payment Innovation
Recent Articles
- Celebrate the Holidays with Incredible Gifts from Five Below
- Tandoori Pizza Expands with Eight New Locations in 2024
- Bridging the Technological Divide: Insights from Omnia's Report
- Jeeves and KLAS Arch Collaborative Enhance EHR Solutions
- American Battery Factory Partners with Tinci for Growth
- Vitreus Token (wVTRS) Launch on MEXC Global: A New Era
- Carbliss Unveils Expansion Plans in Major City Markets
- Complete Solar Welcomes Dan Myers as EVP of New Homes Division
- Housing Market Update: Inventory Rises Amid Sales Slump
- Rani Therapeutics Secures $10M in Direct Offering Funds
- Alzamend Neuro Achieves Nasdaq Compliance: A New Chapter Ahead
- Primary Care Center of Clear Lake Expands Obesity Medicine Team
- 89bio to Showcase Pegozafermin Trial Insights at Major Conference
- Olive My Pickle Celebrates Launch of The Pickle Factory Store
- Immuneering Gains Orphan Drug Status for Groundbreaking Cancer Therapy
- Discover Godiva's Premium Heritage Collection of Chocolates
- Workhorse W56 Launches into Production with Key Certifications
- BioVie Advances Terlipressin Patents and Clinical Innovations
- DeepHow Enhances Workforce Training via SAP Store Integration
- Join scPharmaceuticals' KOL Webinar to Learn About FUROSCIX
- RTI International Collaborates with Codetta Bio for Healthcare Advancements
- Junee Limited Secures $100M Partnership for AI Advancement
- ETC's Strong Sales Growth in Latest Fiscal Quarter
- Carmela Coffee Expands with New Café Location in Florida
- Newton Golf's Strategic Expansion into Japan's Golf Market
- Hudson Technologies Plans Conference Call for Q3 Financial Insights
- Vir Biotechnology Set to Share Groundbreaking Hepatitis Trial Results
- Galecto Enhances Leadership with Dr. Amy Wechsler's Appointment
- BMO Elevates S&P Global's Stock Target Amid Strong Performance
- HeartCore Teams Up with NTT Data for Enhanced Website Solutions
- Comprehensive Overview on Celsius Holdings' Market Position
- CVR Partners Plans to Unveil Third Quarter Financials Soon
- Alto Ingredients Reports Exciting Developments in Production
- Needham Adjusts ViaSat Stock Target Amid Competition and Supply Issues
- Yoshiharu Global Partners with Chengdu Octaday for Growth
- BMO Adjusts Constellation Brands Target Price, Maintains Rating
- Banzai Partners with MZ Group to Enhance Investor Relations
- Expion360 Gears Up for LD Micro Main Event with New Insights
- Apple's Ambitious Car Project Ends Amidst Competition Shifts
- UnitedHealth Group's Q3 Performance: Insights and Analysis
- Citigroup Faces Challenges as Profit Declines in Recent Quarter
- Progressive Insurance Reports Impressive Q3 2024 Financials
- Statkraft AS Advances Sustainability with New Green Bonds
- Ciena Corp's Future Looks Bright Despite Recent Downgrade
- Investigation Looms Over ADMA Biologics Amid Auditor Departure
- Progressive Beats Earnings Estimates with Strong Revenue Growth
- Serious Concerns for Acadia Healthcare Following Stock Plummet
- Coeptis Therapeutics to Showcase Innovations at Key Conferences
- DT Midstream to Reveal Q3 Financial Outcomes and Call Schedule
- Investors Rally Around Serra Ventures' Ag & Food Tech Fund II